Disrupt CAD IV With the Shockwave Coronary IVL System
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregg W Stone, MD
Columbia University
Study Chair - Shigeru Saito, MD
Shonan Kamakura General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tenjinkai Shin-Koga Hospital
Kurume, Fukuoka, Japan
- Sapporo Higashi Tokushukai Hospital
Sapporo, Hokkaido, Japan
- Sakurakai Takahashi Hospital
Kobe, Hyōgo, Japan
- Higashi-Takarazuka Satoh Hospital
Takarazuka, Hyōgo, Japan
- Shonan-Kamakura General Hospital
Kamakura, Kanagawa, Japan
- Johas Kanto Rosai Hospital
Kawasaki, Kanagawa, Japan
- Kyoto-Katsura Hospital
Kyoto, Kyoto, Japan
- Miyazaki Medical Association Hospital
Miyazaki, Miyazaki, Japan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2019
- Primary completion
- 8 May 2020
- Completion
- 25 Mar 2022
- Last update posted
- 22 May 2023
- Registered enrollment
- 72
- Registry id
- NCT04151628
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.